Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient

Med Clin (Barc). 2022 Dec 23;159(12):e81-e82. doi: 10.1016/j.medcli.2022.08.003. Epub 2022 Aug 29.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Critical Illness / therapy
  • Heparin* / adverse effects
  • Humans
  • Hypertriglyceridemia* / drug therapy
  • Hypoglycemic Agents
  • Insulin / therapeutic use
  • Triglycerides

Substances

  • Heparin
  • Insulin
  • Hypoglycemic Agents
  • Triglycerides